Epigenetics Market: By Enzymes (DNA polymerase, Acetylases, DNA ligases, Methyltransferase, RNA ligases, Reverse Transcriptase, Others), By Instruments (Next Generation Sequencers, Mass Spectrometers, Sonicators, qPCRs, Others), By Application (Oncology, Cardiovascular Diseases, Metabolic Diseases, Inflammatory Diseases, Infectious Diseases), By Kits and Assays (Deep Sequencing Kit, Bisulfate Conversion Kit, Methyltransferase Assays, Chip- Seq Kits, Immunoprecipitation Kits, Histone Assay), By End-User (Pharmaceutical and Biotechnological Companies, Contract Research Companies, Academic and Research Institutes), and Geography.  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Epigenetics Market size was valued at US$ 823 Million in 2022 and is projected to reach US$ 2021.73 Million at a CAGR of 13.7% from 2023- 2029. Epigenetics is a study of heritable changes in gene expression which involves the change in phenotype without changing genotype, which in turn affects the reading of genes by cells. Epigenetic changes are natural and regular processes but are also influenced by various factors like lifestyle, environment, age, and state of disease. Epigenetic modifications can manifest a common manner of cells that differentiate terminally to end up as liver cells, skin cells, brain cells, etc. Epigenetic change may have more damaging effects which can lead to diseases like cancer. Systems like histone modification, non-coding RNA-associated gene silencing, and DNA methylation are considered for the initiation of epigenetic change sustainably. In October 2016 Episode an epigenetics data company launched SEED a novel male fertility test to evaluate epigenetic changes on DNA to detect a risk of infertility and poor embryo development.

Epigenetics Market Key Developments:
  • In June 2011, Cayman chemical company adopted the Genedata screener of Genedata, the company of advanced software solutions for drug discovery and life science research as a data management platform for cayman's new epigenetic screening laboratory.

Global Epigenetics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

13.7%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Epigenetics Market Dynamics

The surge in the prevalence of cancer, improving funds and aids for the R&D activities, rise in the partnerships between pharmaceutical and biotechnology companies and research institutes, increase in epigenetics application in non-oncology diseases will propel the epigenetics. Moreover, improved advancements in epigenetics technology, untapped potential of emerging markets like India and China are expected to offer many opportunities for the growth of epigenetics market. However, high instrument cost and the dearth of skilled personnel are expected to hamper the growth of the market.

Key Features of the Reports

  • The epigenetics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Epigenetics Market Segmentation

By Enzymes
  • DNA polymerase
  • Acetylases
  • DNA ligases
  • Methyltransferase
  • RNA ligases
  • Reverse Transcriptase
  • Others
By Instruments
  • Next generation sequencers
  • Mass spectrometers
  • Sonicators
  • qPCRs
  • Others
By Application
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Inflammatory Diseases
  • Infectious Diseases
By Kits and Assays
  • Deep Sequencing Kit
  • Bisulfate Conversion Kit
  • Methyltransferase Assays
  • Chip- Seq Kits
  • Immunoprecipitation Kits
  • Histone Assay
By End User
  • Pharmaceutical and Biotechnological Companies
  • Contract Research Companies
  • Academic and Research Institutes

Frequently Asked Questions

The epigenetics market key players are: Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), New England Biolabs, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Genedata AG(Switzerland), Cayman chemical company (U.S), Active Motif (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Diagenode, Inc. (Belgium), Zymo Research Corporation (U.S.)., Episona Inc. (U.S).

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary
2. Global Epigenetics Market Introduction 
2.1.Global Epigenetics Market  - Taxonomy
2.2.Global Epigenetics Market  - Definitions
2.2.1.Enzymes
2.2.2.Instruments
2.2.3.Application
2.2.4.Kits and Assays
2.2.5.Region
3. Global Epigenetics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Epigenetics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Epigenetics Market  By Enzymes, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. DNA polymerase
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Acetylases
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. DNA ligases
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Methyltransferase
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. RNA ligases
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Reverse Transcriptase
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6. Global Epigenetics Market  By Instruments, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Next generation sequencers
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Mass spectrometers
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Sonicators
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. qPCRs
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Epigenetics Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Oncology
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cardiovascular Diseases
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Metabolic Diseases
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Inflammatory Diseases
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Infectious Diseases
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Epigenetics Market  By Kits and Assays, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Deep Sequencing Kit
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Bisulfate Conversion Kit
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Methyltransferase Assays
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Chip- Seq Kits
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Immunoprecipitation Kits
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
8.6. Histone Assay
8.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.6.3. Market Opportunity Analysis 
9. Global Epigenetics Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Enzymes Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.DNA polymerase
10.1.2.Acetylases
10.1.3.DNA ligases
10.1.4.Methyltransferase
10.1.5.RNA ligases
10.1.6.Reverse Transcriptase
10.1.7.Others
10.2.  Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Next generation sequencers
10.2.2.Mass spectrometers
10.2.3.Sonicators
10.2.4.qPCRs
10.2.5.Others
10.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Oncology
10.3.2.Cardiovascular Diseases
10.3.3.Metabolic Diseases
10.3.4.Inflammatory Diseases
10.3.5.Infectious Diseases
10.4.  Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Deep Sequencing Kit
10.4.2.Bisulfate Conversion Kit
10.4.3.Methyltransferase Assays
10.4.4.Chip- Seq Kits
10.4.5.Immunoprecipitation Kits
10.4.6.Histone Assay
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.DNA polymerase
11.1.2.Acetylases
11.1.3.DNA ligases
11.1.4.Methyltransferase
11.1.5.RNA ligases
11.1.6.Reverse Transcriptase
11.1.7.Others
11.2.  Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Next generation sequencers
11.2.2.Mass spectrometers
11.2.3.Sonicators
11.2.4.qPCRs
11.2.5.Others
11.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Oncology
11.3.2.Cardiovascular Diseases
11.3.3.Metabolic Diseases
11.3.4.Inflammatory Diseases
11.3.5.Infectious Diseases
11.4.  Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Deep Sequencing Kit
11.4.2.Bisulfate Conversion Kit
11.4.3.Methyltransferase Assays
11.4.4.Chip- Seq Kits
11.4.5.Immunoprecipitation Kits
11.4.6.Histone Assay
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.DNA polymerase
12.1.2.Acetylases
12.1.3.DNA ligases
12.1.4.Methyltransferase
12.1.5.RNA ligases
12.1.6.Reverse Transcriptase
12.1.7.Others
12.2.  Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Next generation sequencers
12.2.2.Mass spectrometers
12.2.3.Sonicators
12.2.4.qPCRs
12.2.5.Others
12.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Oncology
12.3.2.Cardiovascular Diseases
12.3.3.Metabolic Diseases
12.3.4.Inflammatory Diseases
12.3.5.Infectious Diseases
12.4.  Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Deep Sequencing Kit
12.4.2.Bisulfate Conversion Kit
12.4.3.Methyltransferase Assays
12.4.4.Chip- Seq Kits
12.4.5.Immunoprecipitation Kits
12.4.6.Histone Assay
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.DNA polymerase
13.1.2.Acetylases
13.1.3.DNA ligases
13.1.4.Methyltransferase
13.1.5.RNA ligases
13.1.6.Reverse Transcriptase
13.1.7.Others
13.2.  Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Next generation sequencers
13.2.2.Mass spectrometers
13.2.3.Sonicators
13.2.4.qPCRs
13.2.5.Others
13.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Oncology
13.3.2.Cardiovascular Diseases
13.3.3.Metabolic Diseases
13.3.4.Inflammatory Diseases
13.3.5.Infectious Diseases
13.4.  Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Deep Sequencing Kit
13.4.2.Bisulfate Conversion Kit
13.4.3.Methyltransferase Assays
13.4.4.Chip- Seq Kits
13.4.5.Immunoprecipitation Kits
13.4.6.Histone Assay
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.DNA polymerase
14.1.2.Acetylases
14.1.3.DNA ligases
14.1.4.Methyltransferase
14.1.5.RNA ligases
14.1.6.Reverse Transcriptase
14.1.7.Others
14.2.  Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Next generation sequencers
14.2.2.Mass spectrometers
14.2.3.Sonicators
14.2.4.qPCRs
14.2.5.Others
14.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Oncology
14.3.2.Cardiovascular Diseases
14.3.3.Metabolic Diseases
14.3.4.Inflammatory Diseases
14.3.5.Infectious Diseases
14.4.  Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Deep Sequencing Kit
14.4.2.Bisulfate Conversion Kit
14.4.3.Methyltransferase Assays
14.4.4.Chip- Seq Kits
14.4.5.Immunoprecipitation Kits
14.4.6.Histone Assay
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Illumina, Inc. (U.S.)
15.2.2.Abcam plc. (U.K)
15.2.3.QIAGEN N.V. (Netherland)
15.2.4.New England Biolabs, Inc. (U.S.)
15.2.5.Merck & Co. (U.S.)
15.2.6.Sigma-Aldrich Corporation (U.S.)
15.2.7.Genedata AG(Switzerland)
15.2.8.Cayman chemical company (U.S)
15.2.9.Active Motif (U.S.)
15.2.10.Thermo Fisher Scientific, Inc., (U.S.)
15.2.11.Diagenode, Inc. (Belgium)
15.2.12.Zymo Research Corporation (U.S.).
15.2.13.Episona Inc. (U.S).
16. Research Methodology 
17. Appendix and Abbreviations 
  • Illumina, Inc. (U.S.)
  • Abcam plc. (U.K)
  • QIAGEN N.V. (Netherland)
  • New England Biolabs, Inc. (U.S.)
  • Merck & Co. (U.S.)
  • Sigma-Aldrich Corporation (U.S.)
  • Genedata AG(Switzerland)
  • Cayman chemical company (U.S)
  • Active Motif (U.S.)
  • Thermo Fisher Scientific, Inc., (U.S.)
  • Diagenode, Inc. (Belgium)
  • Zymo Research Corporation (U.S.).
  • Episona Inc. (U.S).